Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 1/20 | 0.39 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.38 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.37 |
| ▸ | HTT | P42858 | 1/20 | 0.36 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.35 |
| ▸ | MGLL | Q99685 | 2/20 | 0.35 |
| ▸ | PHGDH | O43175 | 1/20 | 0.35 |
| ▸ | CHKA | P35790 | 3/20 | 0.34 |
| ▸ | HRH4 | Q9H3N8 | 2/20 | 0.34 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.32 |
| ▸ | CA2 | P00918 | 1/20 | 0.32 |
| ▸ | NCF1 | P14598 | 1/20 | 0.32 |
| ▸ | PRMT6 | Q96LA8 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| N-Methylpiperidine SCHEMBL11878290 | 1.00 | LMNA (0.39) | LMNATDP1CYP1A2KDM4EHTT | |
| SCHEMBL17771605 | 1.00 | LMNA (0.39) | LMNATDP1CYP1A2KDM4EHTT | |
| SCHEMBL16015284 | 1.00 | LMNA (0.39) | LMNATDP1CYP1A2KDM4EHTT | |
| SCHEMBL19677596 | 0.96 | LMNA (0.43) | LMNATDP1CYP1A2KDM4EHTT | |
| SCHEMBL12952612 | 0.96 | HRH3 (0.37) | LMNATDP1CYP1A2KDM4EHTT | |
| N-Methylpiperidine SCHEMBL6660565 | 0.96 | HRH3 (0.37) | LMNATDP1CYP1A2KDM4EHTT | |
| SCHEMBL20124473 | 0.96 | HRH3 (0.37) | LMNATDP1CYP1A2KDM4EHTT | |
| SCHEMBL21960469 | 0.96 | HRH3 (0.37) | LMNATDP1CYP1A2KDM4EHTT | |
| SCHEMBL22228575 | 0.96 | TDP1 (0.40) | LMNATDP1CYP1A2KDM4EHTT | |
| N-Methylpiperidine SCHEMBL1920 | 0.96 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220396595-A1 | A METAL COMPLEX AND USE THEREOF | RHODIA OPERATIONS (FR) | 2022-12-15 | — | — | US | claimed |
| CN-114599772-A | Metal complexes and their use | 罗地亚经营管理公司 | 2022-06-07 | — | — | CN | claimed |
| US-20200231910-A1 | BLEACH OR DETERGENT COMPOSITION | RHODIA OPERATIONS (FR) | 2020-07-23 | — | — | US | claimed |
| CN-119490893-A | Liquid formulations comprising alcohol and high water-soluble manganese complex salt catalysts, bleaching formulations and cleaners comprising the same | 卡特赛尔有限公司 | 2025-02-21 | — | — | CN | disclosed |
| CN-117285990-A | Composition comprising a protonated triazacyclic compound and manganese (II) acetate, preparation thereof, bleaching agent and cleaning agent | 韦尔化学性能产品有限公司 | 2023-12-26 | — | — | CN | disclosed |
| CN-116583585-A | Particles comprising a protonated triazacyclic compound and bleaching and cleaning agents comprising the same | 韦尔化学性能产品有限公司 | 2023-08-11 | — | — | CN | disclosed |
| US-20220396595-A1 | A METAL COMPLEX AND USE THEREOF | RHODIA OPERATIONS (FR) | 2022-12-15 | — | — | US | disclosed |
| CN-114599772-A | Metal complexes and their use | 罗地亚经营管理公司 | 2022-06-07 | — | — | CN | disclosed |
| US-20200231910-A1 | BLEACH OR DETERGENT COMPOSITION | RHODIA OPERATIONS (FR) | 2020-07-23 | — | — | US | disclosed |
| EP-0902021-B1 | Cyclic polyamine salts | CLARIANT GMBH (DE) | 2005-07-06 | — | — | EP | disclosed |
| EP-0902021-A2 | Cyclic polyamine salts | Clariant GmbH (DE) | 1999-03-17 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220396595-A1 | A METAL COMPLEX AND USE THEREOF | SOD1, MPO, GPX4 | LMNA 3104/4885TDP1 3532/4885CYP1A2 3371/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.